Review of data presented at recent conferences on newer therapies for neovascular age-related macular degeneration and diabetic macular edema. This online activity is designed to update clinicians on data presented at meetings of retina specialists; these include the Retina World...

This online activity is designed to update clinicians on data presented at the 25th EURETINA Congress that was held from September 4 to 7, 2025, in Paris, France; the 59th Annual Meeting of the Retina Society that was held on...

In the rapidly expanding oncology treatment landscape, multidisciplinary care is essential for managing any treatment-related adverse events. This program will provide eye care clinicians with the knowledge and competence to manage ocular toxicities associated with antibody-drug conjugates, monoclonal antibodies, and...

This online, on-demand virtual symposium brings together renowned experts in dry eye disease (DED). In this educational program, these experts use a case-based format to discuss the latest data regarding the management of DED and share their perspectives and best...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

The BURST CME™ format is an online, on-demand video program designed to deliver concise, modular education. In these modules, Uday Devgan, MD, FACS, FRCS, reviews presbyopia-correcting intraocular lenses (IOLs) and toric IOLs for patients with astigmatism. Topics discussed include the...

Despite growing awareness of the role of newer anti-VEGF agents in the management of neovascular age-related macular degeneration (nAMD), diabetic macular edema (DME), and retinal vein occlusion (RVO), retina specialists may still face challenges in extending patients’ treatment intervals with...

Designed for today’s eye care professionals, EyeCon delivers practical strategies you can apply immediately in practice. Explore the latest advances in diagnostic technologies, emerging therapies, and clinical trial data shaping the future of eye care.

Although anti-VEGF therapies have advanced the management of nAMD and DME, limitations with their use – including the need for frequent injections – led to the development of newer anti-VEGF agents. In this program, a panel of expert faculty share...